Brief: MyMD Pharmaceuticals Plans FDA-Cleared Phase 2 Clinical Trial of MYMD-1 in Rheumatoid Arthritis

Q/C Technologies

06/12/2023 14:16

Dec 6 (Reuters) - MyMD Pharmaceuticals Inc  MYMD.O :
    * MYMD PHARMACEUTICALS PLANS FDA-CLEARED PHASE 2 CLINICAL
TRIAL OF
MYMD-1 IN RHEUMATOID ARTHRITIS
    * MYMD PHARMACEUTICALS INC - COMPANY TARGETS Q1 2024 FOR
TRIAL
INITIATION

Source text for Eikon:  ID:nBw9NMCjTa 
Further company coverage:  MYMD.O 

 ((Reuters.Briefs@thomsonreuters.com;))